Veracyte: Phillip Febbo, M.D. to join as chief scientific officer and CMO Oct. 2

Veracyte announced that Phillip G. Febbo, M.D., will join the company on October 2 as chief scientific officer and chief medical officer. Febbo, a distinguished industry and academic leader, will lead Veracyte’s global team of research and development, medical affairs, clinical affairs, quality, regulatory affairs, and lab director professionals to help advance novel tests that address important unmet patient-care needs in cancer. He will report to Marc Stapley, Veracyte’s chief executive officer.